
ASSOCIATION OF VARIANTS IN THE CP, ATOX1
AND COMMD1 GENES WITH WILSON DISEASE
SYMPTOMS IN LATVIA Zarina A1,2*, Tolmane I3,4, Krumina Z2, Tutane AI1, Gailite L1 *Corresponding Author: Ms. Agnese Zarina, Scientific Laboratory of Molecular Genetics, Rīga Stradiņš
University, 16 Dzirciema Street, Riga, Latvia, LV-1007. Tel.: +371-6706-1542. Fax: +371-67-471-815.
E-mail: agnese.zarina@rsu.lv or zarina.agnese@gmail.com page: 37
|
RESULTS
The majority of the WD patients expressed hepatological
symptoms as the first manifestation (detailed
segregation of the WD patients according to their first
symptoms and age of onset can be found in Table 1). A
detailed description of WD patient genotypes in the ATP7B
gene, clinical and biochemical findings can be found in the
Supplemental Table 1. All identified variants corresponded
to the Hardy-Weinberg equilibrium in the analyzed WD
patient group (p >0.05).
The CP Gene. In the CP gene promoter, seven allelic
variants were observed: rs66508328, rs67870152,
rs16861642, rs73020328, rs73166855, rs66953613 and
rs11708215. As the first six of the variants mentioned
above are in strong linkage (r2 = 1) (see Table 2), one of
them was analyzed, rs66508328 along with rs11708215 (r2
= 0.562 from the 1000 genome project) [17], the frequency
of which differed from the other variants.
None of the variants in the WD patients was statistically
significantly different from those described in the GnomAD database. Next, the frequency of alleles and genotypes (according
to different inheritance models) was compared with
the first clinical manifestation and genotype of the ATP7B
gene (see Table 3). No statistically significant differences
were found between allele frequencies and the first clinical
manifestations of WD. Statistically significant differences
were found between the two analyzed variants and the
ATP7B genotype, rs66508328 variant AA genotype and the
rs11708215 variant GG genotype (both according to recessive
inheritance model) were more common in WD patients with
the unconfirmed genotype by ATP7B gene molecular testing.
The ATOX1 Gene. Four patients (out of 64) were
found to have one allelic (intronic) variant, rs571657964
in a heterozygous state [minor alle frequency (MAF) for
patients = 0.023; MAF in European (non Finnish) population
= 0.0058] [16]. Analyzing the variant in the Human
Splicing Finder software (http://www.umd.be/HSF/) [19],
it was predicted that the allelic variant had no effect on
splicing, thus the allelic variant was not included in further
statistical analyses, as it was very unlikely to cause
functional changes of the ATOX1 gene.
The COMMD1 Gene. Three allelic variants were
identified: rs569267407, rs55677935 and rs9096. The frequency
of allelic variants of the COMMD1 gene found in
this study was compared to the GnomAD database. See
results in Table 4. The frequencies of COMMD1 variants did not significantly
differ from the frequencies listed in the GnomAD
database. As the variant rs569267407 is located in the
non coding part of the gene, its potential effect on gene
splicing was analyzed (using the Human Splicing Finder
software) [19]. As the impact was not predicted, the variant
was not further analyzed. The frequency of alleles or
genotypes (by different inheritance models) was compared
to the first clinical symptoms of WD patients (taking into
account only those patients with molecularly confirmed
WD, n = 49). No statistically significant differences were
found between allele and genotype frequencies and the first
clinical manifestations of WD. Comparing the incidence
of both variants (in the dominant inheritance model) and
the age of first symptoms, no differences were observed
(rs9096 p = 0.112; rs55677935 p = 0.146); results are
shown in Table 5.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|